Abstract
We have characterized the molecular defect causing lecithin:cholesterol acyltransferase (LCAT)-deficiency (LCAT-D) in the LCAT gene in three siblings of Austrian descent. The patients presented with typical symptoms including corneal opacity, hemolytic anemia, and kidney dysfunction. LCAT activities in the plasma of these three patients were undetectable. DNA sequence analysis of polymerase chain reaction (PCR)-amplified DNA of all six LCAT exons revealed a new point mutation in exon IV of the LCAT gene, i.e., a G to A substitution in codon 140 converting Arg to His. This mutation caused the loss of a cutting site for the restriction endonuclease HhaI within exon IV: Upon digestion of a 629-bp exon IV PCR product with HhaI, the patients were found to be homozygous for the mutation. Eight of 11 family members were identified as heterozygotes. Transfection studies of COS-7 cells with plasmids containing a wildtype or a mutant LCAT cDNA revealed that, in contrast to the cell medium containing wild-type enzyme, no enzyme activity was detectable upon expression of the mutant protein. This represents strong evidence for the causative nature of the observed mutation for LCAT deficiency in affected individuals and supports the conclusion that Arg140 is crucial for the structure of an enzymatically active LCAT protein.
References
Assmann G, Eckardstein A von, Funke H (1991) Lecithin:cholesterol acyltransferase deficiency and fish eye disease. Curr Opin Lipidol 2:110–117
Carlson LA, Holmquist L (1985) Evidence for the presence in human plasma of lecithin:cholesterol acyltransferase acticity (β-LCAT) specifically esterifying free cholesterol of combined pre-β and β-lipoproteins. Acta Med Scand 218:197–205
Frohlich J, McLeod R (1986) Lecithin:cholesterol acyltransferase syndromes. Adv Exp Med Biol 201:181–194
Funke H, Eckardstein A von, Pritchard PH, Hornby AE, Wiebusch H, Motti C, Hayden MR, Dachet C, Jacotot B, Gerdes U, Faergeman O, Albers JJ, Colleoni N, Catapano A, Frohlich J, Assmann G (1993) Genetic and phenotypic heterogeneity in familial lecithin:cholesterol acyltransferase (LCAT) deficiency; six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest 91:677–683
Glomset JA, Norum KR, Gjone E (1983) Lecithin:cholesterol acyltransferase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease. McGraw Hill, New York, pp 643–654
Gotoda T, Yamada N, Murase T, Sakuma M, Murayama N, Shimano H, Kozaki K, Albers JJ, Yazaki Y, Akanuma Y (1991) Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet 338:778–781
Kingston RE (1987/1988) In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) Current protocols in Molecular Biology. Greene and Wilney-Interscience, New York
McLean J, Fielding C, Drayna D, Dieplinger H, Baer B, Kohr W, Henzel W, Lawn R (1986) Cloning and expression of human lecithin:cholesterol acyltransferase cDNA. Proc Natl Acad Sci USA 83:2335–2339
Meroni G, Malgaretti N, Magnaghi P, Taramelli R (1990) Nucleotide sequence of the cDNA for lecithin:cholesterol acyltransferase (LCAT) from the rat. Nucleic Acids Res 18:5308
Norum KR, Glomset JA, Nichols AV, Forte T, Albers JJ, King WC, Mitchell CD, Applegate KR, Gong EL, Cabana V, Gjone E (1975) Plasma lipoproteins in familial lecithin:cholesterol acyltransferase deficiency: effects of incubation with lecithin:cholesterol acyltransferase in vitro. Scand J Clin Lab Invest 35:31–54
Sanger F, Nicklein S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Skretting G, Prydz H (1992) An amino acid exchange in exon I of the human lecithin:cholesterol acyltransferase (LCAT) gene is associated with fish eye disease. Biochem Biophys Res Commun 182:583–587
Steyrer E, Durovic S, Frank S, Gießauf W, Burger A, Dieplinger H, Zechner R, Kostner GM (1994) The role of lecithin:cholesterol acyltransferase for lipoprotein (a) assembly: structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 94:2330–2340
Taramelli R, Pontoglio M, Candiani G, Ottolenghi S, Dieplinger H, Catapano A, Albers JJ, Vergani C, McLean J (1990) Lecithin:cholesterol acyltransferase deficiency: molecular analysis of a mutated allele. Hum Genet 85:195–199
Warden CH, Langner CA, Gordon JI, Taylor BA, McLean JW, Lusis AJ (1989) Tissue-specific expression, developmental regulation, and chromosomal mapping of lecithin:cholesterol acyltransferase gene. J Biol Chem 264:21573–21581
Yang C-Y, Manoogian D, Pao Q, Lee F, Knapp RD, Gotto Jr AM, Pownall HJ (1987) Lecithin:cholesterol acyltransferase; functional regions and structural model of the enzyme. J Biol Chem 262:3086–3091
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steyrer, E., Haubenwallner, S., Hörl, G. et al. A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency. Hum Genet 96, 105–109 (1995). https://doi.org/10.1007/BF00214196
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00214196